Gaomi Tongli Sugar Co., Ltd. announced that it will receive CNY 20 million in equity round of funding on January 10, 2022. The transaction will include participation from existing investor Zhejiang Huakang Pharmaceutical Co., Ltd. to retain its 100% stake. Upon closing, the registered capital of the company will increase from CNY 0.8 million to CNY 20.8 million.

The transaction has been approved in the sixteenth meeting of the fifth board of directors of investor.